The U.S. Wants Metal Independence - And This Nevada Opportunity Fits the Moment
Washington's push for domestic copper, silver, gold, and tungsten is reshaping the resource landscape. Their neighbor's multi-metal hits, supported by $6M in federal funding and a 300%+ YTD surge, confirmed this Nevada corridor is the right kind of ground. Now another early-stage explorer has stepped into the same trend as interest accelerates.
Shares Stats
| Shares Outstanding | 538,500,000 |
| Shares Float | 537,460,000 |
| Shares Short | 13,360,000 |
| Insider Holdings | 21% |
| Institution Holdings | 83.80% |
About AMGEN Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
General
| Name | AMGEN Inc |
| Ticker | AMGN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 28,000 |
Highlights
| Analyst Target | 323.28 |
| Market Cap | 185,608,900,000 |
| PE Ratio | 26.65 |
| PEG Ratio | 1.05 |
| EBITDA | 16,481,000,448 |
Financials
| Curr Year EPS Estimate | 21.24 |
| Next Quarter EPS Estimate | 5.08 |
| Profit Margin | 19.52% |
| Operating Margin | 28.56 |
| Return on Assets | 0.08 |
| Return on Equity | 0.82 |
| Revenue | 35.9B |
| Earnings Per Share | 12.93 |
| Revenue Per Share | 66.89 |
| Gross Profit | 25,198,000,128 |
| Quarterly Revenue Growth | 0.12 |
Valuation
| Trailing PE | 26.38 |
| Forward PE | 15.20 |
| Price/Sales (Trailing 12 Mt.) | 5.11 |
| Price/Book (Most Recent Quarter) | 18.71 |
Dividend
AMGEN Inc pays out a dividend of $9.62 per share, with a dividend yield of 2.79%.
AMGN's next dividend payment will be made to shareholders on December 12, 2025.
They pay out 119.05% of their earnings out as a dividend.
Recent Dividends
| Dec 12, 2025 | $2.38 |
| Sep 12, 2025 | $2.38 |
| Jun 6, 2025 | $2.38 |
| Mar 7, 2025 | $2.38 |
| Dec 9, 2024 | $2.25 |
| Sep 6, 2024 | $2.25 |
| Jun 7, 2024 | $2.25 |
| Mar 7, 2024 | $2.25 |
Enhanced Games to offer performance enhancers ... and stock ... to the public
The no-drug-testing Enhanced Games is going public in two ways — with a new listing on the Nasdaq stock exchange and also by offering a direct-to-consumer business focused on performance products in a move it says “aims to democratize access to performance enhancement tools and protocols.”
XRP Surges 7% As ETFs Get Ready To Launch: How High Can It Go?
XRP (CRYPTO: XRP) is up 7% on Monday as traders positioned for potential ETF-driven momentum after five spot XRP exchange-traded funds are getting ready to launch.
Global Demand for Defense Metals Is Surging 7X - Ad
Lithium, uranium and titanium are at the center of a global race. Nations are scrambling to secure them for fighter jets, EVs, and reactors. One N. American project could help fill the West's critical-minerals gap.
These 8 Democrats voted with Republicans on the government shutdown deal. Here's how they explain it
WASHINGTON (AP) — The Democratic senators — eight in total — faced almost instant blowback from members of their own party as to allow the Senate to move forward on that would reopen the government.
Officials scour charred site of Kentucky UPS plane crash for victims and answers
LOUISVILLE, Ky. (AP) — The grim task of finding victims from the firestorm that followed the in Louisville, Kentucky, entered a third day Thursday as investigators gather information to determine why the aircraft caught fire and lost an engine on takeoff.
Legally "Skim" $6,361 Into Your Account? - Ad
A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.
Warren Buffett Only Has Couple Of Rules For People Who Want To Work For Him, But Here's One Habit He Particularly Detests
Buffett instructs Berkshire Hathaway employees to think like owners and report bad news immediately. He values long-term investments and integrity.
Amazon's $150 Billion AI Capex Surge Could Force Its First Big Bond Deal In Years
Amazon may need to tap Wall Street for funds as it faces rising AI and data center spending, despite sitting on $84 billion in cash.
Elon's Optimus to Mint New "Musk Millionaires" as Soon as Jan 26? - Ad
Elon Musk may be set to create more "Musk Millionaires" as soon as January 26... Because on that day, he's expected to officially launch his Optimus robot... An AI-powered robot that Elon himself says will be capable of "doing anything bar nothing". Now, it's important to point out that Elon hasn't released it to the public yet... But ahead of the launch, one Silicon Valley insider has identified a "backdoor way" for any American to invest in Optimus with a regular brokerage account...
Jury Deadlocks After Three Days in MIT Brothers' $25 Million Cryptocurrency Heist Trial
A Manhattan federal judge declared a mistrial in the high-profile cryptocurrency fraud case involving James and Anton Peraire-Bueno, who are MIT graduates. The brothers were accused of a $25 million fraud related to cryptocurrency.
AstraZeneca's Investigational Hypertension Drug Shows Significant Blood Pressure Control In Pivotal Trial
AstraZeneca's Baxdrostat cut blood pressure by 14 mmHg in the Phase 3 Bax24 trial, showing strong efficacy and safety in resistant hypertension patients.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit the most.
Trump-Pardoned Ponzi Schemer Faces 37-Year Sentence For $44 Million COVID Scam
A previously convicted Ponzi schemer who had received a pardon from President Trump is heading back to prison due to involvement in a new fraudulent scheme.
Donald Trump Fueled Bitcoin's Rise Beyond $100,000 — Can BTC Survive His 2028 Exit?
Bitcoin (CRYPTO: BTC) may face its biggest political stress test yet in 2028 when President Donald Trump leaves office and the pro-crypto admin
Why Is a $116B Mining Giant Backing a $10M Firm? - Ad
Rio Tinto rarely makes early-stage bets. Yet one small N. American firm earned its trust with projects in lithium, uranium, and titanium - all vital to U.S. defense and energy independence.
How To Earn $500 A Month From HP Stock Ahead Of Q4 Earnings
HP offers an annual dividend yield of 4.75% ($1.16 a year). How can investors exploit its dividend yield to pocket a regular $500 monthly?
Trump Withdraws Support For 'Wacky' Marjorie Taylor Greene In Sudden, Fiery Split: 'I Can't Take...'
President Donald Trump said he is withdrawing his endorsement of longtime ally Rep. Marjorie Taylor Greene — here's what happened.
Elon's New Device Could Launch Biggest IPO of the Decade - Ad
Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.
Cipher Mining Stock Pops As JPMorgan Moves To Overweight
Cipher Mining shares are rising Monday after JPMorgan upgraded the stock to Overweight and raised its price target to $18.
TSMC Chief CC Wei Says Nvidia CEO 'Wants More Chips' As Jensen Huang Enjoys Hotpot In Taipei And Praises The Taiwanese Foundry: 'No TSMC, No Nvidia'
Nvidia CEO Jensen Huang praised TSMC as vital to his company's success during his Taiwan visit, where he met TSMC chief CC Wei over hotpot and reportedly requested more chips amid surging AI demand and U.S. export restrictions.
Why Are 21 Billionaires Moving Their Money ASAP? - Ad
One of the biggest stock market events in 25 years is rapidly unfolding... The economist who predicted the 2008 Financial Crisis says it will be: "The Biggest Crash of Our Lifetime." It could cut the entire tech marketing by HALF.
JPMorgan Says Chevron Investor Day Will Highlight Oil, Gas, LNG Market Dynamics
Chevron's 2025 Investor Day will focus on disciplined capital spending, dividend growth and technological innovation, according to JPMorgan analyst Arun Jayaram.
Zohran Mamdani Says No More Thanking Veterans Today, Forgetting Tomorrow — Trump, Obama And Others Express Gratitude For Service
America's top political and tech leaders — including Donald Trump, Barack Obama, Tim Cook, and Sundar Pichai — marked Veterans Day 2025 with tributes honoring the courage and sacrifice of U.S. service members.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
Starbucks' Bearista Cup Resale Market Explodes, Labubu-Level Frenzy Ensues
Starbucks has seen a surge in demand for its collectible holiday merchandise, with the Glass Bearista Cold Cup becoming the latest sensation.
Some Social Security Recipients Won't Have To Wait Until 2026 For COLA Hike
Social Security and SSI recipients will receive a 2.8% cost-of-living adjustment in 2026, with SSI beneficiaries seeing the increase a day earlier due to a federal holiday.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.
Quantum Computer That Could 'Hack Everyone's Crypto': Why Eric Jackson Is Betting On BTQ Technologies As His Next 100-Bagger
Eric Jackson names BTQ his next 100-bagger, betting it can stop quantum computers from "hacking everyone's crypto."
TSLA, PLTR, IREN And More: 5 Stocks That Dominated Investor Buzz This Week
Retail investors talked up five hot stocks this week (Nov. 3–7) on X and Reddit's r/WallStreetBets: TSLA, PLTR, MSTR, AMD, IREN.
The U.S. Wants Metal Independence - And This Nevada Opportunity Fits the Moment - Ad
Washington's push for domestic copper, silver, gold, and tungsten is reshaping the resource landscape. Their neighbor's multi-metal hits, supported by $6M in federal funding and a 300%+ YTD surge, confirmed this Nevada corridor is the right kind of ground. Now another early-stage explorer has stepped into the same trend as interest accelerates.
Investigators look into 'repeating bell' heard during takeoff of UPS cargo plane that crashed
LOUISVILLE, Ky. (AP) — A repeating bell sounded in the cockpit for 25 seconds as pilots tried to control a UPS cargo plane that caught fire, had an engine fall off and this week in Louisville, Kentucky, a National Transportation Safety Board member said Friday.
Small Caps, Pharma Surge As AI Rotation Broadens, Nvidia Tumbles: What's Moving Markets Tuesday?
Wall Street's sector rotation entered full throttle Tuesday, with investors pouring into previously overlooked corners of the market amid an AI-driven shift that now favors undervalued small caps and defensive names such as health care.
Global Demand for Defense Metals Is Surging 7X - Ad
Lithium, uranium and titanium are at the center of a global race. Nations are scrambling to secure them for fighter jets, EVs, and reactors. One N. American project could help fill the West's critical-minerals gap.
Anthony Scaramucci Calls Zohran Mamdani's Win An 'Anger-Based Reaction' To Boomer Policies, Says New NYC Mayor Could Become 'Popular' If...
Anthony Scaramucci, the founder of SkyBridge Capital, described Zohran Mamdani’s victory in New York City's mayoral race as an “anger-based reaction” by the young people against the policies of the boomer generation's political elites.
Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk
NEW YORK (AP) — U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-loss treatments Ozempic and Wegovy.
Legally "Skim" $6,361 Into Your Account? - Ad
A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.
Taylor Swift, Elon Musk, Donald Trump, MrBeast — Robinhood Just Made Their Mojo Tradable
Robinhood has new prediction markets for its customers, with a focus on the entertainment sector. Here are some of the new markets.
Trump's Tariffs Face Doubts In Supreme Court: 'Major Questions Doctrine' Looms Large Amid Debate Over President's Emergency Powers
The U.S. Supreme Court raised doubts regarding President Donald Trump's authority to impose sweeping tariffs using a decades-old emergency powers law.
Elon's Optimus to Mint New "Musk Millionaires" as Soon as Jan 26? - Ad
Elon Musk may be set to create more "Musk Millionaires" as soon as January 26... Because on that day, he's expected to officially launch his Optimus robot... An AI-powered robot that Elon himself says will be capable of "doing anything bar nothing". Now, it's important to point out that Elon hasn't released it to the public yet... But ahead of the launch, one Silicon Valley insider has identified a "backdoor way" for any American to invest in Optimus with a regular brokerage account...
Palantir CEO Alex Karp Blasts Short Sellers Again As Stock Drops 11% This Week, Deems It 'Market Manipulation'
Palantir CEO Alex Karp takes aim at those betting against the stock as the software company's shares fell 11% this week.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.